组织工程与重建外科杂志 ›› 2025, Vol. 21 ›› Issue (3): 287-.

• • 上一篇    下一篇

手术治疗罕见肢体巨大畸形PROS患儿一例报道及文献复习

  

  • 出版日期:2025-06-02 发布日期:2025-07-01

Surgical treatment of a child with PROS,a rare giant limb deformity:A case report and review of the literature

  • Online:2025-06-02 Published:2025-07-01

摘要: PIK3CA相关过度生长谱(PROS)是一类与PIK3CA基因突变相关的罕见疾病,主要表现为血管异常及软组织 过度生长。尽管近年来特异性靶向通路抑制剂的临床应用取得了一定进展,但仍有部分患者存在耐药或治疗效果不佳 的问题。本文报道了一例右上肢巨大畸形的 PROS患儿。患儿自出生后即发现颈部、胸背及双上肢多发肿物,逐年增 大,其中前胸及右上肢尤为明显。右上肢逐渐增粗,并伴发脊柱变形、右肩关节脱位及胸廓畸形。既往接受西罗莫司口 服治疗及多次局部减容治疗,均未达到理想治疗效果。二代基因测序结果显示,患儿存在ERBB2和PDGFRA基因位点 的错义变异。由于口服靶向药物治疗和局部减容治疗均不能使病变得到长期改善,患儿右上肢肥大畸形严重,导致肢 体功能完全丧失,最终通过截肢手术解决了患儿的临床问题。本文通过对该病例的总结,进一步补充和完善了 PROS 相关基因突变的研究,为该疾病的诊断和治疗提供了新的参考依据。

关键词: &emsp, PIK3CA相关过度生长谱, &emsp, 重度肢体肥大畸形, &emsp, 手术治疗, &emsp, PI3K-AKT-mTOR信号通路, &emsp, 体细胞突变

Abstract: PIK3CA-associated overgrowth spectrum (PROS) is a class of rare diseases associated with mutations in the PIK3CA gene, which is mainly characterized by vascular abnormalities and soft tissue overgrowth. Although the clinical application of specific targeted pathway inhibitors has made some progress in recent years, some patients still suffer from drug resistance or poor therapeutic effects. In this paper, a child of PROS with a giant deformity of the right upper limb was reported. The child was found to have multiple swellings on the neck, chest, back, and both upper limbs since birth, which increased in size year by year. Among them, the anterior chest and the right upper limb were particularly obvious. The right upper limb gradually thickened, and was accompanied by spinal deformity, right shoulder dislocation and thoracic deformity. The patient had received sirolimus oral treatment and several times of localized volume reduction treatment, but failed to achieve the desired therapeutic effect. Second-generation gene sequencing showed that the child had missense variants at the ERBB2 and PDGFRA loci. Because oral targeted drug therapy and localized volume reduction therapy could not lead to longterm improvement of the lesion, and the child had severe hypertrophic deformity of the right upper limb, resulting in complete loss of limb function, the child’s clinical problem was finally solved by amputation surgery. By summarizing this case, this paper further supplemented and improved the study of PROS-related gene mutations, providing a new reference for the diagnosis and treatment of this disease.

Key words: PIK3CA-associated overgrowth spectrum, &emsp, Severe limb hypertrophy deformity, &emsp, Surgical treatment, &emsp, PI3K-AKT-mTOR signaling pathway, &emsp, Somatic mutation